Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

426 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Use of a recombinant human follicle-stimulating hormone:recombinant human luteinizing hormone (r-hFSH:r-hLH) 2:1 combination for controlled ovarian stimulation during assisted reproductive technology treatment: A real-world study of routine practice in the Russian Federation.
Koloda Y, Korsak V, Rozenson O, Anshina M, Sagamonova K, Baranov I, Yakovenko S, D'Hooghe T, Ershova A, Lispi M. Koloda Y, et al. Best Pract Res Clin Obstet Gynaecol. 2022 Dec;85(Pt B):134-148. doi: 10.1016/j.bpobgyn.2022.01.009. Epub 2022 Feb 2. Best Pract Res Clin Obstet Gynaecol. 2022. PMID: 35216907 Free article.
Ovarian hyperstimulation syndrome and complications of ART.
Vloeberghs V, Peeraer K, Pexsters A, D'Hooghe T. Vloeberghs V, et al. Best Pract Res Clin Obstet Gynaecol. 2009 Oct;23(5):691-709. doi: 10.1016/j.bpobgyn.2009.02.006. Epub 2009 Jul 25. Best Pract Res Clin Obstet Gynaecol. 2009. PMID: 19632900 Review.
Reduced FSH and LH action: implications for medically assisted reproduction.
Bosch E, Alviggi C, Lispi M, Conforti A, Hanyaloglu AC, Chuderland D, Simoni M, Raine-Fenning N, Crépieux P, Kol S, Rochira V, D'Hooghe T, Humaidan P. Bosch E, et al. Hum Reprod. 2021 May 17;36(6):1469-1480. doi: 10.1093/humrep/deab065. Hum Reprod. 2021. PMID: 33792685 Free PMC article. Review.
Optimising Follicular Development, Pituitary Suppression, Triggering and Luteal Phase Support During Assisted Reproductive Technology: A Delphi Consensus.
Orvieto R, Venetis CA, Fatemi HM, D'Hooghe T, Fischer R, Koloda Y, Horton M, Grynberg M, Longobardi S, Esteves SC, Sunkara SK, Li Y, Alviggi C. Orvieto R, et al. Front Endocrinol (Lausanne). 2021 May 10;12:675670. doi: 10.3389/fendo.2021.675670. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34040586 Free PMC article.
Comparative effectiveness of recombinant human follicle-stimulating hormone alfa (r-hFSH-alfa) versus highly purified urinary human menopausal gonadotropin (hMG HP) in assisted reproductive technology (ART) treatments: a non-interventional study in Germany.
Bühler KF, Fischer R, Verpillat P, Allignol A, Guedes S, Boutmy E, Bilger W, Richter E, D'Hooghe T. Bühler KF, et al. Reprod Biol Endocrinol. 2021 Jun 16;19(1):90. doi: 10.1186/s12958-021-00768-3. Reprod Biol Endocrinol. 2021. PMID: 34134695 Free PMC article.
Economic evaluation of Medically Assisted Reproduction: An educational overview of methods and applications for healthcare professionals.
Luyten J, Connolly MP, Verbeke E, Buhler K, Scotland G, Lispi M, Revelli A, Borget I, Cedrin-Durnerin I, D'Hooghe T. Luyten J, et al. Best Pract Res Clin Obstet Gynaecol. 2022 Dec;85(Pt B):217-228. doi: 10.1016/j.bpobgyn.2022.01.008. Epub 2022 Feb 2. Best Pract Res Clin Obstet Gynaecol. 2022. PMID: 35219590 Free article. Review.
Originator recombinant human follitropin alfa versus recombinant human follitropin alfa biosimilars in Spain: A cost-effectiveness analysis of assisted reproductive technology related to fresh embryo transfers.
Schwarze JE, Venetis C, Iniesta S, Falla E, Lukyanov V, de Agustin Calvo E, D Hooghe T, Roeder C, Matorras R. Schwarze JE, et al. Best Pract Res Clin Obstet Gynaecol. 2022 Dec;85(Pt B):203-216. doi: 10.1016/j.bpobgyn.2022.01.011. Epub 2022 Feb 8. Best Pract Res Clin Obstet Gynaecol. 2022. PMID: 35227619 Free article. Review.
Cost-effectiveness analysis of recombinant human follicle-stimulating hormone alfa(r-hFSH) and urinary highly purified menopausal gonadotropin (hMG) based on data from a large German registry.
Bühler K, Roeder C, Schwarze JE, Lispi M, Allignol A, Falla E, Lukyanov V, D Hooghe T, Fischer R. Bühler K, et al. Best Pract Res Clin Obstet Gynaecol. 2022 Dec;85(Pt B):188-202. doi: 10.1016/j.bpobgyn.2022.02.002. Epub 2022 Feb 16. Best Pract Res Clin Obstet Gynaecol. 2022. PMID: 35304097 Free article.
426 results